Florian Sulzmaier

Florian Sulzmaier currently serves as the Director of Pharmacology at Enlaza Therapeutics, a position held since May 2023. Previously, Florian was with Inhibrx, Inc. from November 2015 to May 2023, progressing through roles of Associate Director, Group Leader, and Scientist focusing on biotherapeutics. Earlier experience includes a Postdoctoral Research Fellowship at UC San Diego, where Florian characterized Focal Adhesion Kinase signaling in ovarian cancer, and another Postdoctoral Fellowship at The Research Corporation of the University of Hawai'i, investigating glioblastoma multiforme tumor progression. Academic qualifications include a PhD in Molecular Biosciences and Bioengineering from the University of Hawaii at Manoa, complemented by an MS and BS in Biochemistry from the Technical University of Munich.